These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4423206)

  • 1. Glucose- and tolbutamide-mediated insulin response after preinfusion with ethanol.
    Kuhl C; Andersen O
    Diabetes; 1974 Oct; 23(10):821-6. PubMed ID: 4423206
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of ethanol on stimulus-induced insulin secretion and glucose tolerance. A study of mechanisms.
    Shah JH; Wongsurawat N; Aran PP
    Diabetes; 1977 Apr; 26(4):271-7. PubMed ID: 849808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the action of tolbutamide in normal man. II. Modulation of glucose-induced insulin release by tolbutamide.
    Widström A; Cerasi E
    Acta Endocrinol (Copenh); 1973 Mar; 72(3):519-31. PubMed ID: 4739359
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
    Devrim S; Koniçe M; Sencer E; Molvalìlar S; Alp H
    Isr J Med Sci; 1972 Jun; 8(6):815-20. PubMed ID: 5051802
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of ethanol and its metabolites on insulin secretion.
    Bivens CH; Feldman JM
    Q J Stud Alcohol; 1974 Jun; 35(2):635-48. PubMed ID: 4610627
    [No Abstract]   [Full Text] [Related]  

  • 7. Some aspects of "acute phase" insulin release in healthy subjects.
    Siegal AM; Kreisberg RA; Owen WC; Fox OJ
    Diabetes; 1972 Mar; 21(3):157-62. PubMed ID: 5011981
    [No Abstract]   [Full Text] [Related]  

  • 8. Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide.
    Rojas L; Soeldner JS; Gleason RE; Kahn CB; Marble A
    J Clin Endocrinol Metab; 1969 Dec; 29(12):1569-79. PubMed ID: 4899852
    [No Abstract]   [Full Text] [Related]  

  • 9. Basal and stimulated insulin levels: comparison of insulinogenic effects of oral glucose and intravenous tolbutamide in nondiabetic and diabetic subjects.
    Bagdade JD; Bierman EL; Porte D
    Metabolism; 1971 Nov; 20(11):1000-7. PubMed ID: 5115750
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentiation of the plasma insulin response to glucose by prior administration of alcohol. An apparent islet-priming effect.
    Metz R; Berger S; Mako M
    Diabetes; 1969 Aug; 18(8):517-22. PubMed ID: 4897290
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of 6-aminonicotinamide on insulin release and C-14 glucose oxidation by isolated pancreatic rat islets: difference between glucose, tolbutamide and aminophylline.
    Ammon HP; Steinke J
    Endocrinology; 1972 Jul; 91(1):33-8. PubMed ID: 4260250
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of the blood glucose level for plasma insulin response to intravenously administered tolbutamide in healthy subjects.
    Cerasi E; Chowers I; Luft R; Widström A
    Diabetologia; 1969 Oct; 5(5):343-8. PubMed ID: 5360814
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin release during post-tolbutamide glucose test. Its effect in children with decreased insulin reserve.
    Cresto JC; Dujovne IL; Sires JM; Aparicio NJ; De Majo SF
    Medicina (B Aires); 1977; 37(2):133-8. PubMed ID: 331023
    [No Abstract]   [Full Text] [Related]  

  • 14. Diurnal variation in the blood-sugar and plasma-insulin response to tolbutamide.
    Baker IA; Jarrett RJ
    Lancet; 1972 Nov; 2(7784):945-7. PubMed ID: 4116824
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of the pancreatic B-cell stimulation in subjects with normal metabolism].
    Grabner W; Bergner D; Scharrer H; Sommer B; Berg G
    Klin Wochenschr; 1971 Jul; 49(13):763-5. PubMed ID: 4935070
    [No Abstract]   [Full Text] [Related]  

  • 16. [B-cell stimulation in chronic and chronic relapsing pancreatitis].
    Grabner W; Bergner D; Scharrer H; Sommer B; Berg G
    Klin Wochenschr; 1971 Jul; 49(13):765-7. PubMed ID: 4935071
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T; Lauridsen UB; Madsen SN; Mogensen P
    Dan Med Bull; 1972 Oct; 19(7):222-6. PubMed ID: 5079926
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin.
    Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF
    Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419
    [No Abstract]   [Full Text] [Related]  

  • 20. [The insulinemic response after oral administration of glucose and after intravenous administration of tolbutamide in patients with Cushin's syndrome].
    Muggeo M; Tiengo A; Avogaro P; Crepaldi G; Enzi G; Trisotto A; Federspil G
    Acta Isot (Padova); 1967 Dec; 7(1):99-116. PubMed ID: 5612077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.